Understanding the Role of Litter Decomposition in Restoration of Fly Ash Ecosystem.

Plant species possess a huge potential in restoration of fly ash ecosystem. Litter deposition and its decomposition in the ash deposited sites are two important processes of the fly ash ecosystem. In order to identify the biological potential of a plant species to aid restoration of fly ash deposited sites, it is needed to assess leaf litter decomposition as well as nutrient release pattern. In the present investigation, we studied the leaf litter decomposition of the plant species (Leucaena leucocephala, Pithecellobium dolce and Prosopis juliflora) and mix plantation in the fly ash ecosystem. The litter bag experiment was conducted in the area of plantation on the fly ash deposited site during a period of 365 days. Percentage of C and N was higher in L. leucocephala > P. dolce >Mix Plantation > P. juliflora while C/N ratio was higher in P. juliflora >Mix Plantation > L. leucocephala > P. dolce. L. leucocephala and P. dolce showed relatively fast decomposition rates (k = 1.27, 1.17), respectively while mix plantation (k = 0.82) and P. juliflora (k = 0.73) exhibited relatively slower decomposition rates. Thus, we noted that the decomposition rate of L. leucocephala was greater than the other selected species. This shows that the species having faster decomposition rate and nutrient release could be a factual choice for rehabilitation of fly ash deposited sites.

Tree growth rate regulate the influence of elevated CO2 on soil biochemical responses under tropical condition.

Tree growth rate can complicate our understandings of plant belowground responses to elevated CO2 (eCO2) in tropical ecosystems. We studied the effects of eCO2 on plant growth parameters, and rhizospheric soil properties including soil organic carbon (SOC), glomalin related soil protein (GRSP), microbial biomass C (Cmic), CO2 efflux (Cefflux), and microbial extracellular enzyme activities under two tropical tree saplings of fast-growing Tectona grandis (Teak) and slow-growing Butea monosperma (Butea). We exposed these saplings to eCO2 (∼550 ppm) and ambient CO2 (aCO2; ∼395 ppm) in the Indo-Gangetic plain region, and further (after 10 and 46 months) measured the changes in their rhizospheric soil properties. With respect to aCO2 treatment, eCO2 significantly increased plant height, stem and shoot weight, and total plant biomass of Teak. However, these plant traits did not considerably differed between eCO2 and aCO2 treatments of Butea. The eCO2 induced greater extent of increase in rhizospheric soil properties including SOC fractions (particulate OC, non-particulate OC and total OC), GRSP fractions (easily extractable- GRSP, difficulty extractable- GRSP and total- GRSP), Cmic, Cefflux and extracellular enzyme activities (phosphatase, dehydrogenase, ß-glucosidase and fluorescein diacetate) were observed under Teak compared with Butea. Compared with aCO2 treatment, eCO2 slightly reduced soil available N and P under the Teak, but no changes were apparent between eCO2 and aCO2 treatments of the Butea. The greater extent of responses from soil variables observed after longer period (46 months) of CO2 exposure. The multivariate analysis confirmed that eCO2 treatment with Teak is more responsive compared with other treatments of Teak and Butea. This contrasting rhizospheric soil feedback to eCO2 between two tropical trees, suggesting fast-growing species will be more responsive to future climate. Such species will have a competitive advantage over coexisting less responsive species (e.g. Butea) under future eCO2 climate.

Contribution of glomalin to dissolve organic carbon under different land uses and seasonality in dry tropics.

Glomalin related soil protein (GRSP) is a hydrophobic glycoprotein that is significant for soil organic carbon (SOC) persistence and sequestration, owing to its large contribution to SOC pool and long turnover time. However, the contribution of GRSP to dissolve OC (DOC) leach from soil is not yet comprehensively explored, though it could have implication in understanding SOC dynamics. We, therefore, aim to measure the contribution of GRSP to DOC, in a range of land uses and climatic seasons in the dry tropical ecosystem. Our results demonstrated that a significant proportion of GRSP (water soluble GRSP; WS-GRSP) leached with DOC (7.9-21.9 mg kg-1), which accounts for 0.2-0.23% of soils total GRSP (T-GRSP). Forest exhibited significantly higher WS-GRSP and DOC leaching than fallow and agriculture. WS-GRSP and DOC accumulations were higher in the dry season (summer and winter) than in rainy. The extent of seasonal variations was higher in forest than in other two land uses, indicating the role of vegetation and biological activity in soil dissolve organic matter (DOM) dynamics. The regression analysis among WS-GRSP, T-GRSP, DOC and SOC prove that the accumulations and leaching of GRSP and other soil OM (SOM) depend on similar factors. The ratio of WS-GRSP-C to DOC was higher in agriculture soil than in forest and fallow, likely a consequence of altered soil chemistry, and organic matter quantity and quality due to soil management practices. Multivariate analysis reflects a strong linkage among GRSP and SOC storage and leaching, soil nutrients (nitrogen and phosphorus) and other important soil properties (pH and bulk density), suggesting that improving GRSP and other SOM status is an urgent need for the both SOC sequestration and soil health in dry tropical agro-ecosystems.

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal.

BACKGROUND: Despite direct-acting antivirals (DAA), aims to "eradicate" viral hepatitis by 2030 remain unlikely. In Nepal, an expert consortium was established to treat HCV through Nepal earthquakes aftermath offering a model for HCV treatment expansion in a resource-poor setting. METHODOLOGY/PRINCIPAL FINDINGS: In 2015, we established a network of hepatologists, laboratory experts, and community-based leaders at 6 Opioid Substitution Treatment (OST) sites from 4 cities in Nepal screening 838 patients for a treatment cohort of 600 individuals with HCV infection and past or current drug use. During phase 1, patients were treated with interferon-based regimens (n = 46). During phase 2, 135 patients with optimal predictors (HIV controlled, without cirrhosis, low baseline HCV viral load) were treated with DAA-based regimens. During phase 3, IFN-free DAA treatment was expanded, regardless of HCV disease severity, HIV viremia or drug use. Sustained virologic response (SVR) was assessed at 12 weeks. Median age was 37 years and 95.5% were males. HCV genotype was 3 (53.2%) or 1a (40.7%) and 32% had cirrhosis; 42.5% were HIV-HCV coinfected. The intention-to-treat (ITT) SVR rates in phase 2 and 3 were 97% and 81%, respectively. The overall per-protocol and ITT SVR rates were 97% and 85%, respectively. By multivariable analysis, treatment at the Kathmandu site was protective and substance use, treatment during phase 3 were associated with failure to achieve SVR. CONCLUSIONS/SIGNIFICANCE: Very high SVR rates may be achieved in a difficult-to-treat, low-income population whatever the patient's profile and disease severity. The excellent treatment outcomes observed in this real-life community study should prompt further HCV treatment initiatives in Nepal.

Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.

As part of a comprehensive health care programme for people who use drugs in Nepal, HIV and viral hepatitis B and C status--including risk factors, HCV-genotypes and co-infections--as well as two IL28B Single-nucleotide polymorphisms (SNPs) were assessed for a random sample of 401 people who inject drugs in three regions of Nepal: mid-western Terrai (Nepalgunj), the eastern region (Dharan, Biratnagar) and the central region (Kathmandu, Lalitpur and Chitwan). Individuals were included who showed at least a minimum of health care seeking behaviour. This latter criterion was defined by being registered with any organisation offering health services. The average age of the participants was 30.5 yrs, and the average length of intravenous drug use was 8.5 yrs. The prevalence rates of HBsAg, anti-HIV antibodies and HCV-RNA were 3.5%, 13.8% and 41.9%, respectively. Spontaneous HCV clearance was evident in 16% of all of those who tested positive for anti-HCV antibodies. Independent risk factors for HCV-RNA positivity were age, gender, geographical region, duration of injecting drug use, history of imprisonment and HIV co-infection. In the age group ≤24 yrs, the rate of spontaneous HCV clearance was 43.5%. Overall, 59.8% of HCV infections were caused by HCV genotype 3 and 40.2% by HCV genotype 1. No other HCV genotypes were identified in this study. The IL28B SNP rs12979860 and rs8099917 were identified in 122 patients, and 75.4% of all participants had both favourable genotypes rs12979860 C/C and rs8099917 T/T.